1Safety analysis and selection of excipients for intrathecal drugsZHANG Xia, YAO Shang-chen, NING Bao-ming, LI Jin, SUN Hui-min1457-14632Traditional Chinese medicine preparations in medical institutions:current situation and thoughts on achievement translation pathLIN Tao, FAN Heng-rui, LI Ming-duo, ZHANG Li-cai, CHEN Shao-jun1464-14713Exploring risk factors and improvement strategies for quality management in non-clinical drug safety evaluation institutions based on on-site inspectionsYUAN Ming, CHEN Yi-fei1472-14774Comparison of research status of gene therapy drugs at home and abroad based on bibliometric analysisJIA Wan-ru, WANG Hui-ye, DONG Li1478-14875Analysis of dilemmas and research on relief paths in infringement litigation of invention patents for traditional Chinese medicineHAN Chu-yu, DENG Yong1488-14936Discussion on the focus of pharmaceutical research for generic peritoneal dialysis fluidsMENG Yong-gang1494-14977Preliminary considerations on optimizing the dispute resolution path of drug registration procedureLU Jian, SUN Tan-lin, BAI Yu1498-15018Sodium zirconium cyclosilicate:research progress on a novel potassium binderYANG Shi-jie, ZHUANG Jie, LIU Qian, NIU Jian-zhao1502-15099An introduction to tablet in tablet technology and discussion on pharmaceutical researchPAN Jing, HUANG Xiao-long1510-151510Historical evolution of malt processing,modern research progress and prediction and analysis of quality markersSU Yin, WANG Xin, ZHONG Ling-yun, LU Tu-lin, ZENG Jin-xiang, ZHU Jing1516-152611Preparation and in vitro-in vivo evaluation of lasmiditan tabletsJIA Jun-wei, HAN Jian-cheng, WANG Hui, WANG Chun, FENG Zhong1527-153812Uncertainty evaluation of determination of polysaccharide content in Haemophilus influenzae type b conjugate vaccine by UV spectrophotometryDUAN Yan, JI Hong1539-154413Clinical comprehensive evaluation of proprotein convertase subtilisin kexin 9 monoclonal antibodies based on the Quick Guideline for Drug Evaluation and Selection in Chinese Medical Institutions(the 2nd edition)MA Juan-juan, CHENG Jie, JU Xiao-yu, SUN Jie-wei, WANG Yun-huan1545-155214Efficacy and safety analysis of sugemalimab as first-line treatment for non-small cell lung cancerLIU Fen, YIN Gui-sen, PAN Yong, YUAN Xia, LI Jin-lan1553-155815Cost-effectiveness analysis of tirzepatide and semaglutide for treatment of patients with type 2 diabetes mellitus in ChinaZHANG Jing, LIU Guo-qiang, GAO Sheng-nan, GAO Ning, ZHANG Yu-xi, XIE Hao1559-1568 